[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100509956":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":82,"collaborators":84,"id":93,"slug":20,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":20,"eligibilityCriteria":98,"healthyVolunteers":94,"sex":99,"minAge":100,"maxAge":101,"enrollmentInfo":102,"targetDuration":20,"studyType":105,"phases":106,"briefSummary":108,"conditions":109,"keywords":20,"overallStatus":48,"whyStopped":20,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Neuracle Medical Technology(Shanghai) Co.,Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"single","EXPERIMENTAL","Patients with motor disability（Complete or incomplete quadriplegia due to spinal cord injury, brain stem stroke, amyotrophic lateral sclerosis and other motor neuron disorders).\n\nImplantation of NEO device.",[13],"Device: NEO",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","NEO","Subjects will be implanted with the NEO device.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Tao Liu, Master","CONTACT","021-58086056","liutao@neuracle.cn",[28,46,57,67],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Chinese PLA General Hospital","NOT_YET_RECRUITING","Beijing","Beijing Municipality","100039","China",{"type":36,"coordinates":37},"Point",[38,39],116.39723,39.9075,{"lat":39,"lon":38},[42,44],{"name":43,"role":24,"phone":20,"phoneExt":20,"email":20},"Xinguang Yu, Ph.D",{"name":43,"role":45,"phone":20,"phoneExt":20,"email":20},"PRINCIPAL_INVESTIGATOR",{"facility":47,"status":48,"city":31,"state":32,"zip":49,"country":34,"cosmosGeoPoint":50,"geoPoint":52,"contacts":53},"Xuanwu Hospital，Capital Medical University","RECRUITING","100053",{"type":36,"coordinates":51},[38,39],{"lat":39,"lon":38},[54,56],{"name":55,"role":24,"phone":20,"phoneExt":20,"email":20},"Guoguang Zhao, Ph.D",{"name":55,"role":45,"phone":20,"phoneExt":20,"email":20},{"facility":58,"status":48,"city":31,"state":32,"zip":59,"country":34,"cosmosGeoPoint":60,"geoPoint":62,"contacts":63},"Beijing Tiantan Hospital, Capital Medical University","100070",{"type":36,"coordinates":61},[38,39],{"lat":39,"lon":38},[64,66],{"name":65,"role":24,"phone":20,"phoneExt":20,"email":20},"Wang Jia, Ph.D",{"name":65,"role":45,"phone":20,"phoneExt":20,"email":20},{"facility":68,"status":48,"city":69,"state":70,"zip":71,"country":34,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Huashan Hospital Affiliated to Fudan University","Shanghai","Shanghai Municipality","200040",{"type":36,"coordinates":73},[74,75],121.45806,31.22222,{"lat":75,"lon":74},[78,80],{"name":79,"role":24,"phone":20,"phoneExt":20,"email":20},"Liang Chen, Ph.D",{"name":81,"role":45,"phone":20,"phoneExt":20,"email":20},"Liang Chen",{"type":83,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[85,88,90,91],{"name":86,"class":87},"Xuanwu Hospital, Beijing","OTHER",{"name":89,"class":87},"Beijing Tiantan Hospital",{"name":29,"class":87},{"name":92,"class":87},"Huashan Hospital","100509956",false,"NCT05920174","Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability","A Prospective Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability","Inclusion Criteria:\n\n1. Aged between 18 and 80 years of age;\n2. Complete or incomplete quadriplegia due to spinal cord injury, brain stem stroke, amyotrophic lateral sclerosis and other motor neuron disorders;\n3. After the neurological assessment, the brain motor-related cortex is functional, and there is no obvious organic disease or functional disease；\n4. The above diseases have been diagnosed for at least 12 months and stable for at least 6 months after standard treatment；\n5. The patient had normal cognitive function, good compliance and volunteered to participate in the clinical trial.\n\nExclusion Criteria:\n\n1. Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses；\n2. Combined with progressive neurological disease；\n3. Combined with surgical contraindications identified by surgeons and anesthesiologists;\n4. Participating in other clinical trials;\n5. Other conditions deemed inappropriate by investigators and medical staff.","ALL","18 Years","80 Years",{"count":103,"type":104},9,"ESTIMATED","INTERVENTIONAL",[107],"NA","Through brain-computer interface alternative technology, patients can control the external equipment（wheelchairs, robotic arms, the WeChat app and other physical aids）with brain signals to improve the patients quality of life.",[110],"Tetraplegia","2024-12-03",{"date":113,"type":114},"2024-12-05","ACTUAL",{"date":116,"type":114},"2023-10-17",{"date":118,"type":104},"2025-12",{"name":5,"class":6},4]